Literature DB >> 7439241

Maximal exercise power after a single dose of metoprolol and of slow-release metoprolol.

H Folgering, M van Bussel.   

Abstract

The treatment of hypertension with a single daily-dose of a beta-blocker gives rise to high peak-plasma concentrations 1.5 h after ingestion. After slow release-preparations of beta-blockers, the peak concentrations are half those produced by the conventional preparation at the same oral dose. A frequently occurring side-effect of beta-blocker therapy is fatigue. In this study the effect of a single dose of metoprolol 300 mg, 200 mg, 200 mg slow-release and a placebo on maximal exercise power was tested in 6 healthy subjects, 1.5 h and 24 h after ingestion. Maximal exercise power was significantly reduced 1.5 h after ingestion of metoprolol 300 mg and 200 mg. No change was found 1.5 h after 200 mg of a slow-release preparation. The possible reasons for reduced maximal exercise power are discussed. It is concluded that use of a beta-blocker for the treatment of hypertension in a single daily-dose regimen may be a reason to prefer a slow-release preparation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7439241     DOI: 10.1007/bf00563003

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  14 in total

1.  Beta-blockers: once or three times a day?

Authors:  T Reybrouck; A Amery; R Fagard; P Jousten; P Lijnen; E Meulepas
Journal:  Br Med J       Date:  1978-05-27

2.  Plasma levels and negative chronotropic effect of metoprolol following single doses of a conventional and sustained-release formulation.

Authors:  C P Quaterman; M J Kendall; P G Welling
Journal:  Eur J Clin Pharmacol       Date:  1979-03-26       Impact factor: 2.953

3.  Effects of propranolol on several physiological responses during orthostatic and exercise stress in healthy male subjects.

Authors:  M G Maksud; F E Tristani; K D Coutts; J J Barboriak; L H Hamilton
Journal:  Can J Physiol Pharmacol       Date:  1971-10       Impact factor: 2.273

4.  Autonomic blocking drugs on circulatory adaptations at rest and during exercise in man. Pronethalol and poldine in long-term treatment.

Authors:  G Schröder
Journal:  Acta Med Scand       Date:  1968-11

5.  The effects of propranolol and metoprolol on exercise responses in normal man [proceedings].

Authors:  D C Banks; J M Patrick; S B Pearson
Journal:  Br J Clin Pharmacol       Date:  1978-11       Impact factor: 4.335

6.  Haemodynamic long-term effects of metoprolol at rest and during exercise in essential hypertension.

Authors:  P Lund-Johansen; O J Ohm
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

7.  Effects of propranolol and metoprolol on haemodynamic and respiratory indices and on perceived exertion during exercise in hypertensive patients.

Authors:  C L van Herwaarden; R A Binkhorst; J F Fennis; A van't Laar
Journal:  Br Heart J       Date:  1979-01

8.  Hemodynamic response to graded exercise after chronic beta-adrenergic blockade.

Authors:  T Reybrouck; A Amery; L Billiet
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1977-02

9.  Acute haemodynamic effects of metoprolol in hypertensive patients.

Authors:  R Sannerstedt; H Wasir
Journal:  Br J Clin Pharmacol       Date:  1977-02       Impact factor: 4.335

10.  Oxygen debt: effect of beta-adrenergic blockade on the lactacid and alactacid components.

Authors:  R J Barnard; M L Foss
Journal:  J Appl Physiol       Date:  1969-12       Impact factor: 3.531

View more
  6 in total

1.  Twenty-four hour effects of oxprenolol Oros and atenolol on heart rate, blood pressure, exercise tolerance and perceived exertion.

Authors:  M A van Baak; F T Verstappen; B Oosterhuis
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

2.  Maximal aerobic power and blood pressure in normotensive subjects after acute and chronic administration of metoprolol.

Authors:  M van Baak; W Jennen; F T Verstappen
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Exercise haemodynamics and maximal exercise capacity during beta-adrenoceptor blockade in normotensive and hypertensive subjects.

Authors:  M A van Baak; F M Koene; F T Verstappen
Journal:  Br J Clin Pharmacol       Date:  1988-02       Impact factor: 4.335

Review 4.  Exercise performance and beta-blockade.

Authors:  P A Tesch
Journal:  Sports Med       Date:  1985 Nov-Dec       Impact factor: 11.136

5.  Metabolic aspects of maximal exercise performance after slow release metoprolol and after atenolol.

Authors:  H T Folgering; J F Borm; R H van Haaren
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

6.  Antihypertensive activity of once daily metoprolol alone and with chlorthalidone and comparison with a twice daily regimen.

Authors:  G Muiesan; E Agabiti-Rosei; A Carotti; L Corea; P Innocenti; C Montervino; R Prezioso; G Romanelli; M Toso; M Motolese
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.